Literature DB >> 30049481

Variation of Opioid Prescribing Patterns among Patients undergoing Similar Surgery on the Same Acute Care Surgery Service of the Same Institution: Time for Standardization?

Ahmed I Eid1, Christopher DePesa1, Ask T Nordestgaard1, Napaporn Kongkaewpaisan1, Jae Moo Lee1, Manasnun Kongwibulwut1, Kelsey Han1, April Mendoza1, Martin Rosenthal1, Noelle Saillant1, Jarone Lee1, Peter Fagenholz1, David King1, George Velmahos1, Haytham M A Kaafarani2.   

Abstract

BACKGROUND: Diversion of unused prescription opioids is a major contributor to the current United States opioid epidemic. We aimed to study the variation of opioid prescribing in emergency surgery.
METHODS: Between October 2016 and March 2017, all patients undergoing laparoscopic appendectomy, laparoscopic cholecystectomy, or inguinal hernia repair in the acute care surgery service of 1 academic center were included. For each patient, we systematically reviewed the electronic medical record and the prescribing pharmacy platform to identify: (1) history of opioid abuse, (2) opioid intake 3 months preoperatively, (3) number of opioid pills prescribed, (4) prescription of nonopioid pain medications (eg, acetaminophen, ibuprofen), and (5) the need for opioid prescription refills. The mean and range of opioid pills prescribed, as well as their oral morphine equivalent, were calculated.
RESULTS: A total of 255 patients were included (43.5% laparoscopic appendectomy, 44.3% laparoscopic cholecystectomy, and 12.1% inguinal hernia repair). The mean age was 47.5 years, 52.1% were female, 11.4% had a history of opioid use, and 92.5% received opioid prescriptions upon hospital discharge. Only 70.9% of patients were instructed to use nonopioid pain medications. The mean and range of opioid pills prescribed were 17.4; 0-56 (laparoscopic appendectomy), 17.1; 0-75 (laparoscopic cholecystectomy), and 20.9; 0-50 (inguinal hernia repair), while the range of prescribed oral morphine equivalent was 0-600 mg for laparoscopic appendectomy/laparoscopic cholecystectomy and 0-375 mg for inguinal hernia repair. No patients required any opioid medication refills.
CONCLUSION: Even within the same surgical service, wide variation of opioid prescription was observed. Guidelines that standardize pain management may help prevent opioid overprescribing.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30049481     DOI: 10.1016/j.surg.2018.05.047

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  14 in total

1.  Educating Surgical Oncology Providers on Perioperative Opioid Use: Results of a Departmental Survey on Perceptions of Opioid Needs and Prescribing Habits.

Authors:  Heather A Lillemoe; Timothy E Newhook; Timothy J Vreeland; Elsa M Arvide; Whitney L Dewhurst; Elizabeth G Grubbs; Thomas A Aloia; Jean-Nicolas Vauthey; Jeffrey E Lee; Ching-Wei D Tzeng
Journal:  Ann Surg Oncol       Date:  2019-04-01       Impact factor: 5.344

2.  Reduced Opioid Prescription Practices and Duration of Stay after TAP Block for Laparoscopic Appendectomy.

Authors:  Matthew C Hernandez; Eric J Finnesgard; Johnathon M Aho; Martin D Zielinski; Henry J Schiller
Journal:  J Gastrointest Surg       Date:  2019-01-22       Impact factor: 3.452

3.  Tackling the opioid epidemic: Reducing opioid prescribing while maintaining patient satisfaction with pain management after outpatient surgery.

Authors:  Lauren D Allan; Catherine Coyne; Cheryl M Byrnes; Colette Galet; Dionne A Skeete
Journal:  Am J Surg       Date:  2020-05-05       Impact factor: 2.565

4.  Provider education leads to sustained reduction in pediatric opioid prescribing after surgery.

Authors:  Bethany J Slater; Chase G Corvin; Kurt Heiss; Robert Vandewalle; Sohail R Shah; Megan Cunningham; EuniceY Huang; Aaron M Lipskar; Naomi-Liza Denning; Melvin Dassinger; Robert A Cina; David H Rothstein; Jeremy Kauffman; Raquel Gonzalez; Martha-Conley Ingram; Mehul V Raval
Journal:  J Pediatr Surg       Date:  2021-08-08       Impact factor: 2.545

5.  Utilization and evolving prescribing practice of opioid and non-opioid analgesics in patients undergoing lymphadenectomy for cutaneous malignancy.

Authors:  Russell G Witt; Brandon Cope; Yi-Ju Chiang; Timothy Newhook; Heather Lillemoe; Ching-Wei D Tzeng; Iris B Chen; Sarah B Fisher; Anthony Lucci; Jennifer A Wargo; Jeffrey E Lee; Merrick I Ross; Jeffrey E Gershenwald; Justine Robinson; Emily Z Keung
Journal:  J Surg Oncol       Date:  2021-12-14       Impact factor: 2.885

6.  Using provider-focused education toolkits can aid enhanced recovery programs to further reduce patient exposure to opioids.

Authors:  Ankit Sarin; Elizabeth Lancaster; Lee-Lynn Chen; Sima Porten; Lee-May Chen; Jeanette Lager; Elizabeth Wick
Journal:  Perioper Med (Lond)       Date:  2020-07-09

7.  Changing the Default: A Prospective Study of Reducing Discharge Opioid Prescription after Lumpectomy and Sentinel Node Biopsy.

Authors:  Tracy-Ann Moo; Kate R Pawloski; Varadan Sevilimedu; Jillian Charyn; Brett A Simon; Lisa M Sclafani; George Plitas; Andrea V Barrio; Laurie J Kirstein; Kimberly J Van Zee; Monica Morrow
Journal:  Ann Surg Oncol       Date:  2020-07-30       Impact factor: 5.344

8.  General practitioners and management of chronic noncancer pain: a cross-sectional survey of influences on opioid deprescribing.

Authors:  Ruth White; Chris Hayes; Allison W Boyes; Simon Chiu; Christine L Paul
Journal:  J Pain Res       Date:  2019-01-22       Impact factor: 3.133

9.  Persistent Opioid Usage After Urologic Intervention and the Impact of Tramadol.

Authors:  Joel J Wackerbarth; Sandra A Ham; Joshua Aizen; John Richgels; Sarah F Faris
Journal:  Urology       Date:  2021-07-29       Impact factor: 2.649

10.  Impact of a tiered discharge opioid algorithm on prescriptions and patient-reported outcomes after open gynecologic surgery.

Authors:  Sarah Huepenbecker; Robert Tyler Hillman; Maria D Iniesta; Tsun Chen; Katherine Cain; Gabriel Mena; Javier Lasala; Xin Shelley Wang; Loretta Williams; Jolyn S Taylor; Karen H Lu; Pedro T Ramirez; Larissa A Meyer
Journal:  Int J Gynecol Cancer       Date:  2021-06-16       Impact factor: 4.661

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.